Key facts
- This page summarizes Simona King's Form 4 filing for Passage BIO, Inc. (PASG).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 01 Aug 2023, 16:36.
Simona King - 28 Jul 2023 Form 4 Insider Report for Passage BIO, Inc. (PASG)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- PASG
- Reported as of
- 28 Jul 2023
- Net transaction value
- -$10,079
- SEC form
- 4
- Accepted by SEC
- 01 Aug 2023, 16:36:49 UTC
- Prior SEC filing
- 20 Apr 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Edgar Cale, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Simona King filed Form 4 for Passage BIO, Inc. (PASG) on 01 Aug 2023.
Change
- Previous filing in this sequence was filed on 20 Apr 2023.
- Current net transaction value: -$10,079.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PASG
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +31,250
- Change %
- +745%
- Price
- $0.000000
- Shares after
- 35,447
- Date
- 28 Jul 2023
- Ownership
- Direct
- Footnotes
- F1
PASG
transaction
Common Stock
Sale
- Transaction value
- $10,079
- Shares
- -11,453
- Change %
- -32%
- Price
- $0.8800
- Shares after
- 23,994
- Date
- 28 Jul 2023
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PASG
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -31,250
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 28 Jul 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 31,250
- Exercise price
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
Footnote F2
The sale reported on this Form 4 represents an Issuer mandated sale by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs; it does not represent a discretionary trade by the Reporting Person. Pursuant to the Issuer's equity incentive plan, an award recipient's tax withholding obligations must be funded by a "sell to cover" transaction.
Footnote F3
Represents accelerated vesting of RSUs previously granted pursuant to the 2020 Equity Incentive Plan pursuant to a separation agreement between the Reporting Person and the Issuer.